Vincerx Pharma, Inc. (VINC) — DEF 14A Filings
All DEF 14A filings from Vincerx Pharma, Inc.. Browse 4 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (4)
-
Vincerx Pharma Files Proxy Statement for June Meeting
— May 12, 2025 Risk: medium
Vincerx Pharma, Inc. filed its definitive proxy statement (DEF 14A) on May 12, 2025, for its annual meeting on June 18, 2025. The company, formerly known as Lif -
Vincerx Pharma Files 2025 Proxy Statement
— Dec 10, 2024 Risk: low
Vincerx Pharma, Inc. filed a Definitive Proxy Statement (DEF 14A) on December 10, 2024, for its fiscal year ending December 31, 2025. The company, formerly know -
Vincerx Pharma Files Proxy Statement for Annual Meeting
— Jul 8, 2024 Risk: low
Vincerx Pharma, Inc. filed its definitive proxy statement (DEF 14A) on July 8, 2024, for its annual meeting on August 12, 2024. The filing details the company's -
Vincerx Pharma Announces 2024 Annual Meeting of Stockholders on May 23
— Apr 10, 2024 Risk: low
Vincerx Pharma, Inc. (VINC) filed a Proxy Statement (DEF 14A) with the SEC on April 10, 2024. Vincerx Pharma, Inc. will hold its 2024 Annual Meeting of Stockhol
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX